Sequential Belimumab and T-cell Based Therapy in SLE

NCT04447053 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Belimumab Injection [Benlysta]

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]